Cargando…
Amelioration of Autoimmune Diabetes of NOD Mice by Immunomodulating Probiotics
Type 1 autoimmune diabetes is an autoimmune disease characterized by specific destruction of pancreatic β-cells producing insulin. Recent studies have shown that gut microbiota and immunity are closely linked to systemic immunity, affecting the balance between pro-inflammatory and regulatory immune...
Autores principales: | Kim, Tae Kang, Lee, June-Chul, Im, Sin-Hyeog, Lee, Myung-Shik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496355/ https://www.ncbi.nlm.nih.gov/pubmed/33013834 http://dx.doi.org/10.3389/fimmu.2020.01832 |
Ejemplares similares
-
Probiotics as a Potential Immunomodulating Pharmabiotics in Allergic Diseases: Current Status and Future Prospects
por: Sharma, Garima, et al.
Publicado: (2018) -
Tolerance to Proinsulin-1 Reduces Autoimmune Diabetes in NOD Mice
por: Jhala, Gaurang, et al.
Publicado: (2021) -
Implications of Probiotics on the Maternal-Neonatal Interface: Gut Microbiota, Immunomodulation, and Autoimmunity
por: Swartwout, Brianna, et al.
Publicado: (2018) -
The NOD Mouse Beyond Autoimmune Diabetes
por: Aubin, Anne-Marie, et al.
Publicado: (2022) -
WDFY4 deficiency in NOD mice ameliorates autoimmune diabetes and insulitis
por: Ferris, Stephen T., et al.
Publicado: (2023)